Vulvar Squamous Cell Carcinoma clinical trials

Explore recruiting vulvar squamous cell carcinoma clinical trials.

Recruiting vulvar squamous cell carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Vulvar Squamous Cell Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

(APOLLO)Neo-adjuvant Pembrolizumab in vulvar squamous cell carcinoma: a clinical proof-of-concept study

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

COLOMBE - A multicentre, single arm, phase 1/2 study, aiming to assess the safety and efficacy of nivolumab and imiquimod combination in vulvar squamous cell carcinoma patients

France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors (KEYNOTE-158)

Netherlands, France, Denmark, Germany, Norway, Italy +3 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Vulvar Squamous Cell Carcinoma trials by city

Vulvar Squamous Cell Carcinoma clinical trials

Recruiting vulvar squamous cell carcinoma studies right now

Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer.

Agnostic Therapy in Rare Solid Tumors

STRatIfication of Vulvar Squamous Cell Carcinoma by HPV and p53 Status to Guide Excision

E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

Primary Chemoradiation VS. Neoadjuvant Chemotherapy Followed By Surgery As Treatment Strategy For LAVC

Treatment of Metastatic Vulvar Carcinoma With Carboplatin and Paclitaxel Chemotherapy

HRYZ-T101 Injection for HPV18 Positive Solid Tumor

STRatIfication of Vulvar SCC by HPV and p53 Status to Guide Excision

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

Also recruiting in Europe

(APOLLO)Neo-adjuvant Pembrolizumab in vulvar squamous cell carcinoma: a clinical proof-of-concept study

COLOMBE - A multicentre, single arm, phase 1/2 study, aiming to assess the safety and efficacy of nivolumab and imiquimod combination in vulvar squamous cell carcinoma patients

A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors (KEYNOTE-158)

Vulvar Squamous Cell Carcinoma trials by city

Other conditions